Prelude Therapeutics (PRLD)
NASDAQ: PRLD
· Real-Time Price · USD
1.14
-0.08 (-6.56%)
At close: Sep 04, 2025, 3:59 PM
1.17
2.64%
After-hours: Sep 04, 2025, 04:11 PM EDT
-6.56% (1D)
| Bid | 1.05 |
| Market Cap | 62.91M |
| Revenue (ttm) | 7M |
| Net Income (ttm) | -124.32M |
| EPS (ttm) | -1.64 |
| PE Ratio (ttm) | -0.7 |
| Forward PE | -1.42 |
| Analyst | Buy |
| Ask | 1.28 |
| Volume | 52,443 |
| Avg. Volume (20D) | 186,706 |
| Open | 1.21 |
| Previous Close | 1.22 |
| Day's Range | 1.12 - 1.21 |
| 52-Week Range | 0.61 - 5.53 |
| Beta | 1.24 |
About PRLD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PRLD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PRLD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-7.94%
Prelude Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
2 months ago · https://www.defenseworld.net
Two Sigma Investments LP Purchases 174,906 Shares of Prelude Therapeutics Incorporated (NASDAQ:PRLD)Two Sigma Investments LP grew its position in Prelude Therapeutics Incorporated (NASDAQ:PRLD – Free Report) by 307.2% in the fourth quarter, according to its most recent 13F filing with the Secu...